close icon

A Fresh Look At Cigna ‘s Elliott Wave Super Cycle

In a case study article on Cigna, published in October, 2016, we examined how a fundamentally sound and undervalued stock can still drop nearly 90%. The reason for that crash didn’t lie in some company specific issue. Rather it happened to occur during the biggest financial crisis in 80 years.

Nevertheless, we made the point that there was a complete impulse pattern on Cigna ‘s weekly logarithmic chart. According to the Elliott Wave theory, a correction follows every impulse. This is how one could’ve anticipated the huge plunge in this otherwise strong and undervalued business.

Cigna chart sent an early warning in 2007

Above is the chart we based our claim on. The impulse pattern, labeled I-II-III-IV-V, was so clear that any newbie could recognize it. At the 2007 top, Cigna was trading at a three-year trailing P/E ratio of just 14. The company was financially sound, profitable and growing. By any fundamental measure, the stock was a strong buy below $60 a share.

Cigna Sent an Elliott Wave Warning in 2007

The only reason not to invest in Cigna in 2007 was the bearish Elliott Wave setup its weekly chart revealed. Corrections usually erase the entire fifth wave. The anticipated retracement in CI’s case was likely to drag the price down to the support of wave IV near $11. “At that price the stock would be ridiculously cheap, trading at just 3 times earnings”, the bulls would say. Yet, this is exactly what happened.

Cigna crashed to single digit prices in 2008

Wave (II) caused a selloff to just $8 a share, or just over 2 times the company’s 2007 earnings. Cigna was, indeed, ridiculously undervalued in late-2008. That undervaluation, paired with the Elliott Wave rule that once a correction is over, the prior trend resumes, made CI a wonder to behold over the next 13 years.

In May, 2021, the stock climbed to an all-time high of almost $273 a share. In the meantime, the company earned $23 a share in 2020, and is expected to earn over $20 a share in 2021. At $273, Cigna was just as undervalued as it was in 2007, with a 2021 P/E of 13.6.

History Rhyming Itself Again?

Yet, the stock is down 22.7% in the past three months anyway. At its current price of less than $211, Cigna looks like a real bargain. Apart from the never-ending health regulation chatter, the company has never been in a better competitive position. Unfortunately for its shareholders, its weekly chart is once again sending a bearish message.

Cigna stock chart once again sending a bearish message

The updated weekly chart above reveals Cigna ‘s phenomenal surge from the depths of the 2008 crisis. It also shows that an even bigger five-wave impulse has been formed. The 2008 bottom is still marked as the end of wave (II). The following surge to $227.13 in January, 2018, must then be wave (III). Wave (IV), culminating in the coronavirus panic in 2020, dragged Cigna to sub-$120. The rally to $273 by May, 2021, is logically labeled as wave (V).

13 years have passed, Cigna is a bigger and stronger company now. And while the Elliott Wave impulse on its chart is also bigger, it is still the same pattern. The consequences for investors should be similar, as well. A decline to the support of wave (IV) can be expected. From the current price of $211, this translates into a 43% decline to roughly $120.

It looks like the weakness from $273 might be just the start. And if you think that at $120 Cigna would be ridiculously cheap at just 6 times earnings, we agree. That doesn’t make it less likely to happen, though.

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

MongoDB – Bearish Pattern Joins Nosebleed Valuation

MongoDB Inc. is a general purpose database platform developer and provider. The company was founded in 2007, but only came public ten years later – in 2017. During the following four years, the stock has risen from an IPO price of $33 to $515 a share as of last week. So, it is fair to…

Read More »

Pandora Does Things Right. Stock May Need a Breather

When we wrote our previous article on Danish jewelry maker Pandora in December, 2020, the stock was up over three-fold since March. That recovery from DKK 180 to DKK 651 didn’t not come out of the blue, though. It was the result of a bullish setup we managed to identify as early as July 2019.…

Read More »

Match ‘s SP500 Inclusion a Good Excuse to Reach $200

Match Group Inc. rose over 10% in post-market trading Friday following reports that it is going to be included in the S&P 500. The company, which owns Tinder, OkCupid and most other major dating apps in the U.S., has a market cap of over $41B. Despite the anticipated “summer of love”, though, this is not…

Read More »

Cameco Stock Seems to Have Finally Turned a Corner

Uranium spot prices are on the verge of breaking above $34/lb, up over 80% from the bottom of $18/lb reached in late-2016. Cameco, as one of the world’s top uranium producers, is now seeing its stock price rising in tandem. Yesterday, it closed at $19.16 after reaching $21.95 in June. We first covered Cameco in…

Read More »

CBOE Takeover Rumor Lifts Stock to Elliott Wave Target

We first wrote about CBOE Global Markets less than eight months ago. The S&P 500 had already recouped all its COVID selloff losses and was hovering at new all-time highs. CBOE, in contrast, was still down 30% from its 2018 record, trading below $97 a share. For some reason, the market was ignoring the company’s…

Read More »

Ahead of Ulta Beauty ‘s 150% Gain Since Lockdown

Buying shares in a beauty retailer in March 2020 sounded like a crazy, stupid idea. Stock markets around the world were plunging at a record pace amid a global GDP crash resulting from government-enforced lockdowns. People were stockpiling necessities in preparations not to leave their homes in the foreseeable future. With COVID-19 cases rising everywhere,…

Read More »

LKQ Stock On the Verge of Doubling Yet Again

The first and only time we wrote about LKQ Corporation was in late-September, 2020. The stock had just doubled from its coronavirus plunge and was hovering around $27. Despite the recent strength, however, we thought the shares still present a good investment. In a time of crisis one cannot rely on charts alone, so the…

Read More »

More analyses